Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 4/2017

01-04-2017 | Clinical Investigation

Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment

Authors: Paul Bazeries, Francine Paisant-Thouveny, Sultan Yahya, Antoine Bouvier, Cosmina Nedelcu, Francoise Boussion, Loic Sentilhes, Serge Willoteaux, Christophe Aubé

Published in: CardioVascular and Interventional Radiology | Issue 4/2017

Login to get access

Abstract

Objective

To report our clinical practice regarding a case series of retained products of conception (RPOC) with marked vascularity (MV) managed with selective uterine artery embolization (UAE) as first-line treatment.

Methods

This was a monocentric, retrospective study of 31 consecutive cases of RPOC with MV diagnosed by Doppler ultrasound in the context of postpartum/postabortal bleeding. The primary outcome was the absence of rebleeding following embolization.

Results

RPOC with MV occurred after abortion in 27 out of 31 patients (87%). The time elapsed between delivery/abortion and UAE ranged from 1 to 210 days (mean 55.7 ± 45 days). Primary clinical success was achieved in 23 women (74.2%) following a single embolization. In total, 27 out of 31 women (87%) had been exclusively managed by UAE with conservative success. Although procedural success was achieved in this number, six women had a further procedure to evacuate RPOC despite procedural success. Large uterine arteriovenous (AV) shunts associated with RPOC were observed in five cases (16.1%), among which two were successfully treated after a single UAE and one after two UAEs, while hysterectomy was performed in the last two cases despite two and three UAE procedures respectively. RPOC was histologically proven in ten cases (32.2%) including four out of five cases of uterine AV shunt.

Conclusion

RPOC with MV can present with large uterine AV shunt, particularly in case of late management. Uterine artery embolization is an effective and safe first-line treatment, and should be evaluated for this indication in larger prospective trials.
Literature
1.
van den Bosch T, Daemen A, Van Schoubroeck D, Pochet N, De Moor B, Timmerman D. Occurrence and outcome of residual trophoblastic tissue: a prospective study. J Ultrasound Med. 2008;27(3):357–61.CrossRefPubMed
2.
3.
Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol. 1990;76(1):129–35.PubMed
4.
Van den Bosch T, Van Schoubroeck D, Lu C, De Brabanter J, Van Huffel S, Timmerman D. Color Doppler and gray-scale ultrasound evaluation of the postpartum uterus. Ultrasound Obstet Gynecol. 2002;20(6):586–91.CrossRefPubMed
5.
Ben-Ami I, Melcer Y, Smorgick N, Schneider D, Pansky M, Halperin R. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception. Int J Gynaecol Obstet. 2014;127(1):86–9.CrossRefPubMed
6.
Cohen SB, Kalter-Ferber A, Weisz BS, Zalel Y, Seidman DS, Mashiach S, et al. Hysteroscopy may be the method of choice for management of residual trophoblastic tissue. J Am Assoc Gynecol Laparosc. 2001;8(2):199–202.CrossRefPubMed
7.
Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod. 2004;19(2):266–71.CrossRefPubMed
8.
Casikar I, Lu C, Oates J, Bignardi T, Alhamdan D, Condous G. The use of power Doppler colour scoring to predict successful expectant management in women with an incomplete miscarriage. Hum Reprod. 2012;27(3):669–75.CrossRefPubMed
9.
Hooker AB, Aydin H, Brölmann HAM, Huirne JAF. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertil Steril. 2016;105(1):156–64.CrossRefPubMed
10.
Kitahara T, Sato Y, Kakui K, Tatsumi K, Fujiwara H, Konishi I. Management of retained products of conception with marked vascularity. J Obstet Gynaecol Res. 2011;37(5):458–64.CrossRefPubMed
11.
Van den Bosch T, Van Schoubroeck D, Timmerman D. Maximum peak systolic velocity and management of highly vascularized retained products of conception. J Ultrasound Med. 2015;34(9):1577–82.CrossRefPubMed
12.
Kamaya A, Petrovitch I, Chen B, Frederick CE, Jeffrey RB. Retained products of conception: spectrum of color Doppler findings. J Ultrasound Med. 2009;28(8):1031–41.CrossRefPubMed
13.
Jain K, Fogata M. Retained products of conception mimicking a large endometrial AVM: complete resolution following spontaneous abortion. J Clin Ultrasound. 2007;35(1):42–7.CrossRefPubMed
14.
Goyal S, Goyal A, Mahajan S, Sharma S, Dev G. Acquired uterine arteriovenous malformation developing in retained products of conception: a diagnostic dilemma. J Obstet Gynaecol Res. 2014;40(1):271–4.CrossRefPubMed
15.
Kido A, Togashi K, Koyama T, Ito H, Tatsumi K, Fujii S, et al. Retained products of conception masquerading as acquired arteriovenous malformation. J Computer Assist Tomogr. 2003;27(1):88–92.CrossRef
16.
17.
O’Brien P, Neyastani A, Buckley AR, Chang SD, Legiehn GM. Uterine arteriovenous malformations: from diagnosis to treatment. J Ultrasound Med. 2006;25(11):1387–92.CrossRefPubMed
18.
Yoon DJ, Jones M, Taani JA, Buhimschi C, Dowell JD. A systematic review of acquired uterine arteriovenous malformations: pathophysiology, diagnosis, and transcatheter treatment. AJP Rep. 2016;6(1):e6–14.CrossRefPubMed
19.
Hoveyda F, MacKenzie IZ. Secondary postpartum haemorrhage: incidence, morbidity and current management. BJOG Int J Obstet Gynaecol. 2001;108(9):927–30.CrossRef
20.
Weisbrod AB, Sheppard FR, Chernofsky MR, Blankenship CL, Gage F, Wind G, et al. Emergent management of postpartum hemorrhage for the general and acute care surgeon. World J Emerg Surg. 2009;4:43.CrossRefPubMedPubMedCentral
21.
Sellmyer MA, Desser TS, Maturen KE, Jeffrey RB, Kamaya A. Physiologic, histologic, and imaging features of retained products of conception. Radiogr Rev Publ. 2013;33(3):781–96.
22.
Sentilhes L, Vayssière C, Deneux-Tharaux C, Aya AG, Bayoumeu F, Bonnet M-P, et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol. 2016;198:12–21.CrossRefPubMed
23.
John M. Eisenberg Center for Clinical Decisions and Communications Science. Management of Postpartum Hemorrhage: current state of the evidence. In: Comparative effectiveness review summary guides for clinicians [Internet]. Rockville: Agency for Healthcare Research and Quality (US); 2007.
24.
Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial. (miscarriage treatment (MIST) trial). BMJ. 2006;332(7552):1235–40.CrossRefPubMedPubMedCentral
25.
Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014;173:19–22.CrossRefPubMed
26.
Soyer P, Dohan A, Dautry R, Guerrache Y, Ricbourg A, Gayat E, et al. Transcatheter arterial embolization for postpartum hemorrhage: indications, technique, results, and complications. Cardiovasc Intervent Radiol. 2015;38(5):1068–81.CrossRefPubMed
27.
Pellerin O, Bats AS, Di Primio M, Palomera-Ricco A, de Villechenon GP, Fournier L, et al. Postpartum hemorrhage treated with gelfoam slurry embolization using the superselective technique: immediate results and 1 month MRI follow-up. Cardiovasc Intervent Radiol. 2013;36(1):98–104.CrossRefPubMed
28.
Poujade O, Ceccaldi PF, Davitian C, Amate P, Chatel P, Khater C, et al. Uterine necrosis following pelvic arterial embolization for post-partum hemorrhage: review of the literature. Eur J Obstet Gynecol Reprod Biol. 2013;170(2):309–14.CrossRefPubMed
29.
Cottier JP, Fignon A, Tranquart F, Herbreteau D. Uterine necrosis after arterial embolization for postpartum hemorrhage. Obstet Gynecol. 2002;100(5 Pt 2):1074–7.PubMed
30.
Timmerman D, Van den Bosch T, Peeraer K, Debrouwere E, Van Schoubroeck D, Stockx L, et al. Vascular malformations in the uterus: ultrasonographic diagnosis and conservative management. Eur J Obstet Gynecol Reprod Biol. 2000;92(1):171–8.CrossRefPubMed
31.
Rufener SL, Adusumilli S, Weadock WJ, Caoili E. Sonography of uterine abnormalities in postpartum and postabortion patients: a potential pitfall of interpretation. J Ultrasound Med. 2008;27(3):343–8.CrossRefPubMed
32.
Brown JV, Asrat T, Epstein HD, Oglevie S, Goldstein BH. Contemporary diagnosis and management of a uterine arteriovenous malformation. Obstet Gynecol. 2008;112(2 Pt 2):467–70.CrossRefPubMed
33.
Salomon LJ, deTayrac R, Castaigne-Meary V, Audibert F, Musset D, Ciorascu R, et al. Fertility and pregnancy outcome following pelvic arterial embolization for severe post-partum haemorrhage. A cohort study. Hum Reprod. 2003;18(4):849–52.CrossRefPubMed
34.
Eriksson S, Nilsson J, Sturesson C. Non-invasive imaging of microcirculation: a technology review. Med Devices. 2014;7:445–52.
35.
Sentilhes L, Gromez A, Clavier E, Resch B, Verspyck E, Marpeau L. Fertility and pregnancy following pelvic arterial embolisation for postpartum haemorrhage. BJOG Int J Obstet Gynaecol. 2010;117(1):84–93.CrossRef
36.
Gaia G, Chabrot P, Cassagnes L, Calcagno A, Gallot D, Botchorishvili R, et al. Menses recovery and fertility after artery embolization for PPH: a single-center retrospective observational study. Eur Radiol. 2009;19(2):481–7.CrossRefPubMed
37.
Delotte J, Chevallier P, Benoit B, Castillon J-M, Bongain A. Pregnancy after embolization therapy for uterine arteriovenous malformation. Fertil Steril. 2006;85(1):228.CrossRefPubMed
38.
Golan A, Dishi M, Shalev A, Keidar R, Ginath S, Sagiv R. Operative hysteroscopy to remove retained products of conception: novel treatment of an old problem. J Minim Invasive Gynecol. 2011;18(1):100–3.CrossRefPubMed
39.
Jiménez JS, Gonzalez C, Alvarez C, Muñoz L, Pérez C, Muñoz JL. Conservative management of retained trophoblastic tissue and placental polyp with diagnostic ambulatory hysteroscopy. Eur J Obstet Gynecol Reprod Biol. 2009;145(1):89–92.CrossRefPubMed
40.
Lee HY, Shin JH, Kim J, Yoon H-K, Ko G-Y, Won H-S, et al. Primary postpartum hemorrhage: outcome of pelvic arterial embolization in 251 patients at a single institution. Radiology. 2012;264(3):903–9.CrossRefPubMed
41.
Sentilhes L, Gromez A, Clavier E, Resch B, Verspyck E, Marpeau L. Predictors of failed pelvic arterial embolization for severe postpartum hemorrhage. Obstet Gynecol. 2009;113(5):992–9.CrossRefPubMed
42.
Samara ET, Aroua A, De Palma R, Stauffer J-C, Schmidt S, Trueb PR, et al. An audit of diagnostic reference levels in interventional cardiology and radiology: are there differences between academic and non-academic centres? Radiat Prot Dosimetry. 2012;148(1):74–82.CrossRefPubMed
43.
Scheurig-Muenkler C, Powerski MJ, Mueller J-C, Kroencke TJ. Radiation exposure during uterine artery embolization: effective measures to minimize dose to the patient. Cardiovasc Intervent Radiol. 2015;38(3):613–22.CrossRefPubMed
44.
Stecker MS, Balter S, Towbin RB, Miller DL, Vañó E, Bartal G, et al. Guidelines for patient radiation dose management. J Vasc Interv Radiol. 2009;20(7 Suppl):S263–73.CrossRefPubMed
45.
Durfee SM, Frates MC, Luong A, Benson CB. The sonographic and color Doppler features of retained products of conception. J Ultrasound Med. 2005;24(9):1181–6.CrossRefPubMed
Metadata
Title
Uterine Artery Embolization for Retained Products of Conception with Marked Vascularity: A Safe and Efficient First-Line Treatment
Authors
Paul Bazeries
Francine Paisant-Thouveny
Sultan Yahya
Antoine Bouvier
Cosmina Nedelcu
Francoise Boussion
Loic Sentilhes
Serge Willoteaux
Christophe Aubé
Publication date
01-04-2017
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 4/2017
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-016-1543-7

Other articles of this Issue 4/2017

CardioVascular and Interventional Radiology 4/2017 Go to the issue

Clinical Investigation

Prostatic Artery Embolization as an Alternative to Indwelling Bladder Catheterization to Manage Benign Prostatic Hyperplasia in Poor Surgical Candidates

Letter to the Editor

Trerotola Device Fragmentation

Review

Post-procedural Care in Interventional Radiology: What Every Interventional Radiologist Should Know—Part I: Standard Post-procedural Instructions and Follow-Up Care

Letter to the Editor

Regarding “Transarterial Embolization of Anomalous Systemic Arterial Supply to Normal Basal Segments of the Lung”

Clinical Investigation

Spontaneous Intramuscular Hematomas of the Abdomen and Pelvis: A New Multilevel Algorithm to Direct Transarterial Embolization and Patient Management

Case Report

A “Train-Track” Technique in Anatomic Reconstruction of SVC Bifurcation Complicated by Cardiac Tamponade: An Introspection